Target intelligence / Profile preview

Oxysterol-binding protein-like 3 (OSBPL3)

Target
OSBPL3
Molecular classification
Intracellular lipid receptor, Lipid transfer protein, Pleckstrin homology (PH) domain-containing protein, Oxysterol-binding protein family member
01

Overview

Oxysterol-binding protein-like 3 (OSBPL3) is a member of the oxysterol-binding protein family that functions as an intracellular lipid receptor and lipid transfer protein[1][3][7]. OSBPL3 contains an N-terminal pleckstrin homology (PH) domain and a highly conserved C-terminal OSBP-like sterol-binding domain, enabling it to bind specific phosphoinositides and participate in non-vesicular lipid exchange at membrane contact sites such as between the endoplasmic reticulum and plasma membrane[2][3][5][6]. This protein plays critical roles in regulating cell adhesion, cytoskeleton organization, vesicle trafficking, and cellular lipid metabolism[1][3][7]. Aberrant expression or mutation of OSBPL3 is implicated in diverse human cancers and is associated with tumor growth, metastasis, prognosis, and immune microenvironment modulation[1][3]. OSBPL3 is broadly expressed across human tissues, with the highest physiological expression in the parathyroid gland[1]. No approved drugs specifically target OSBPL3, but it is considered a potential therapeutic and prognostic target in oncology and metabolic diseases[1][3][7].

Other names
Oxysterol-binding protein-related protein 3ORP3KIAA0704OSBP3ORP-3OSBP-related protein 3
02

Biological functions

Regulation of cell adhesionRegulation of actin cytoskeletonVesicle transportCellular lipid metabolismCell polarityModulation of cell proliferation and survivalMembrane contact site lipid exchange
03

Disease associations

Cancer (oncogenic roles in colorectal, gastric, bladder, breast, glioblastoma, pancreatic cancers)Metabolic disorders (e.g., fatty liver disease)Short-rib thoracic dysplasia spectrum (Genetic disease association)
04

Safety considerations

Potential role as oncogene in certain cancers, so off-target modulation might have tumorigenic impact[1][3]Pleiotropic physiological roles may complicate therapeutic targeting
05

Biomarkers

OSBPL3 overexpression or mutation as poor prognostic marker in various cancers[1][3]Association with tumor mutational burden (TMB) in multiple cancer types[1]Phosphorylation status at specific sites (e.g. S34, S251, S273; potential biomarker in tumors)[1]

Beyond the preview

Go deeper on Oxysterol-binding protein-like 3 (OSBPL3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxysterol-binding protein-like 3 (OSBPL3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call